Follow‐up of 180 Alcoholic Patients for up to 7 Years After Outpatient Treatment: Impact of Alcohol Deterrents on Outcome
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Objective: (1) To perform a 9‐year study of abstinence, lapse, and relapse in 180 chronic alcoholic patients, participants of the O utpatient L ongterm I ntensive T herapy for A lcoholics (OLITA); (2) To investigate the role of supervised alcohol deterrents (AD) in relapse prevention and as an adjunct for maintenance of long‐term abstinence. Method: This prospective open treatment study evaluates the long‐term course of drinking outcomes and AD use of 180 chronic alcoholics consecutively admitted from 1993 to 2002. Subsamples are compared for (1) sham‐AD versus verum‐AD (disulfiram/calcium carbimide), (2) coped lapses versus finally detrimental lapses versus malignant relapses, and (3) AD use for 13 to 20 versus >20 months. Results: In this 9‐year study, the cumulative probability of not having relapsed was 0.52, and that of not having consumed any alcohol was 0.26. Despite long‐term use, disulfiram/calcium carbimide was well tolerated. Patients on sham‐AD (due to contraindications to verum‐AD) showed higher cumulative abstinence probability than patients on verum (S=0.86 vs. S=0.49, p=0.03). Detrimental lapses and malignant relapses occurred earlier than successfully coped lapses (p<0.001); patients with detrimental lapse and with malignant relapse had fewer days of AD intake and less subsequent days without AD than patients with coped lapse (p<0.001). The cumulative abstinence probability was S=0.75 for patients with long‐term intake compared with S=0.50 for patients who stopped AD between months 13 and 20 (p<0.001). Conclusions: An abstinence rate of >50% in this 9‐year study strongly supports the concept of comprehensive, long‐term outpatient treatment of alcoholics. Supervised, guided intake of AD, also over extended periods, can be used as a predominantly psychologically acting ingredient of successful alcoholism therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moyer, A., Finney, J. W., Swearingen, C. E., & Vergun, P. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00018.x · Cited by 1,092
Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders
Miller, W. R., & Wilbourne, P. L. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00019.x · Cited by 805
How effective is alcoholism treatment in the United States?
Miller, W. R., Walters, S. T., & Bennett, M. E. (2001) · Journal of Studies on Alcohol · doi:10.15288/jsa.2001.62.211 · Cited by 434
Disulfiram Treatment of Alcoholism: A Veterans Administration Cooperative Study
Fuller, R. K. (1986) · JAMA · doi:10.1001/jama.1986.03380110055026 · Cited by 431
Alcoholism treatment by disulfiram and community reinforcement therapy
Azrin, N. H., Sisson, R. W., Meyers, R., & Godley, M. (1982) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/0005-7916(82)90050-7 · Cited by 411
The cost effectiveness of treatment for alcoholism: a first approximation
Holder, H., Longabaugh, R., Miller, W. R., & Rubonis, A. V. (1991) · Journal of Studies on Alcohol · doi:10.15288/jsa.1991.52.517 · Cited by 394
The cost-effectiveness of treatment for alcoholism: a second approximation.
Finney, J. W., & Monahan, S. C. (1996) · Journal of Studies on Alcohol · doi:10.15288/jsa.1996.57.229 · Cited by 186
Does disulfiram have a role in alcoholism treatment today?
FULLER, R. K., & GORDIS, E. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00597.x · Cited by 182
The efficacy of disulfiram: a review of outcome studies
HUGHES, J. C., & COOK, C. C. H. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb03370.x · Cited by 162
Does disulfiram help to prevent relapse in alcohol abuse?
Brewer, C., Meyers, R. J., & Johnsen, J. (2000) · CNS Drugs · doi:10.2165/00023210-200014050-00001 · Cited by 92
Disulfiram Treatment for Alcoholism in Severe Mental Illness
Mueser, K. T., Noordsy, D. L., Fox, L., & Wolfe, R. (2003) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2003.tb00652.x · Cited by 80
Cited by
Schuckit, M. A. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60009-x · Cited by 712
Novel Metals and Metal Complexes as Platforms for Cancer Therapy
Frezza, M., Hindo, S., Chen, D., Davenport, A., Schmitt, S., Tomco, D., & Ping Dou, Q. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791209009 · Cited by 552
Jørgensen, C. H., Pedersen, B., & Tønnesen, H. (2011) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01523.x · Cited by 366
Lingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332
“An open prospective study lasting 9 years reported that 2 years of treatment with disulfiram or calcium carbimide resulted in overall abstinence rates of 50%; however, not all patients could take disulfiram or calcium carbimide so received ‘sham’ treatment, and the authors emphasised the importance of its psychologica…”
BackgroundThe persistence of maladaptive memory: Addiction, drug memories and anti-relapse treatments
Milton, A. L., & Everitt, B. J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.01.002 · Cited by 279
Metadata
- Authors
- Krampe, H., Stawicki, S., Wagner, T., Bartels, C., Aust, C., Rüther, E., Poser, W., & Ehrenreich, H.
- Venue
- Alcoholism: Clinical and Experimental Research
- Publisher
- Wiley
- Published
- 2006-01
- Volume
- 30
- Issue
- 1
- Pages
- 86-95
- ISSN
- 0145-6008 (ISSN-L)
- 1530-0277
- OpenAlex
- W1973886921
- Cited by
- 98
- References
- 11
- FWCI
- 4.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.